Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sheng

Showing results (71-80 of 667) with videos related to

Pageof 67
Sort By:
Drug Discovery Today|November 20, 2025
Mechanisms and interventions in relapsed/refractory extranodal natural killer/T-cell lymphomaQisi Lu, Tao You, Qian Cheng, et al.
Drug Discovery Today|October 6, 2025
Bridging data and drug development: Machine learning approaches for next-generation ADMET predictionNini Fan, Jing Chen, Jinghui Wang, et al.
Cancer Letters|December 11, 2024
Cancer vaccines in focus: The next frontier in immuno-oncologyYuhao Xie, Lu-Qi Cao, Haigan Yang, et al.
Scientific Reports|January 19, 2021
Hsa-miR-494-3p attenuates gene HtrA3 transcription to increase inflammatory response in hypoxia/reoxygenation HK2 CellsQian Gong, Zhi-Ming Shen, Zhe Sheng, et al.
Chinese Journal of Cancer|November 22, 2011
Overexpression of P-glycoprotein induces acquired resistance to imatinib in chronic myelogenous leukemia cellsXing-Xiang Peng, Amit K Tiwari, Hsiang-Chun Wu, et al.
Cancers|October 1, 2014
Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug ResistanceYi-Jun Wang, Yun-Kai Zhang, Rishil J Kathawala, et al.
Chinese Journal of Cancer|October 10, 2013
Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugsRishil J Kathawala, Yi-Jun Wang, Charles R Ashby, et al.
Frontiers in Public Health|June 10, 2021
Features of Cytokine Storm Identified by Distinguishing Clinical Manifestations in COVID-19Wei-Xi Shen, Rong-Cheng Luo, Jing-Quan Wang, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2011
Inhibition of c-Kit, VEGFR-2 (KDR), and ABCG2 by analogues of OSI-930Jay P Patel, Ye-Hong Kuang, Zhe-Sheng Chen, et al.
Drug Discovery Today|September 8, 2022
Successes and failures of immunotherapy for gastric cancerJianzheng Wang, Shuiping Tu, Vivek P Chavda, et al.
Pageof 67

Showing results (71-80 of 667) with videos related to

Sort By:
Pageof 67
Drug Discovery Today|November 20, 2025
Mechanisms and interventions in relapsed/refractory extranodal natural killer/T-cell lymphomaQisi Lu, Tao You, Qian Cheng, et al.
Drug Discovery Today|October 6, 2025
Bridging data and drug development: Machine learning approaches for next-generation ADMET predictionNini Fan, Jing Chen, Jinghui Wang, et al.
Cancer Letters|December 11, 2024
Cancer vaccines in focus: The next frontier in immuno-oncologyYuhao Xie, Lu-Qi Cao, Haigan Yang, et al.
Scientific Reports|January 19, 2021
Hsa-miR-494-3p attenuates gene HtrA3 transcription to increase inflammatory response in hypoxia/reoxygenation HK2 CellsQian Gong, Zhi-Ming Shen, Zhe Sheng, et al.
Chinese Journal of Cancer|November 22, 2011
Overexpression of P-glycoprotein induces acquired resistance to imatinib in chronic myelogenous leukemia cellsXing-Xiang Peng, Amit K Tiwari, Hsiang-Chun Wu, et al.
Cancers|October 1, 2014
Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug ResistanceYi-Jun Wang, Yun-Kai Zhang, Rishil J Kathawala, et al.
Chinese Journal of Cancer|October 10, 2013
Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugsRishil J Kathawala, Yi-Jun Wang, Charles R Ashby, et al.
Frontiers in Public Health|June 10, 2021
Features of Cytokine Storm Identified by Distinguishing Clinical Manifestations in COVID-19Wei-Xi Shen, Rong-Cheng Luo, Jing-Quan Wang, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2011
Inhibition of c-Kit, VEGFR-2 (KDR), and ABCG2 by analogues of OSI-930Jay P Patel, Ye-Hong Kuang, Zhe-Sheng Chen, et al.
Drug Discovery Today|September 8, 2022
Successes and failures of immunotherapy for gastric cancerJianzheng Wang, Shuiping Tu, Vivek P Chavda, et al.
Pageof 67